Abstract #2815

Monitoring Changes of the Tumor Microenvironment Following Administration of a Novel Vascular Disrupting Agent OXi6197 Using Multi-parametric MRI

Heling Zhou¹, James Campbell¹, Zhang Zhang², Debabrata Saha², Rebecca Denney¹, Mary Lynn Trawick³, Kevin G Pinney³, and Ralph P Mason¹

¹Radiology, UT Southwestern Medical Center, Dallas, TX, United States, ²Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, United States, ³Chemistry and Biochemistry, Baylor University, Waco, TX, United States

Vascular disrupting agents (VDAs), selectively damage the endothelial cells of tumor blood vessels, inducing ischemia and consequent hypoxia and cell death. We investigated the impact of a novel indole-based VDA (OXi6197) to tumor perfusion and oxygenation using multi-parametric MRI on a lung tumor animal model. DCE MRI showed decreased blood flow after administration of VDA. Oxygen sensitive MRI, BOLD and TOLD, showed progression of hypoxia at 24 hours. Multimodality imaging provides useful information to evaluate the efficacy of VDA. The findings in this study will be important for dose optimization and potential combination therapy in the future.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.